Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 20, 2002

View Archived Issues

Improved pharmacokinetic profile reported for new nasal nicotine formulation

Improvement of natural learning impairment after administration of H3 receptor antagonists in rats

Daily Z-335 is safe and effectively blocks thromboxane A2 receptors

DAC:Opioid returns mixed results

Crucell licenses PER.C6 cell line for use in GenVec's BioBypass

Adolor enters opioid antagonist license agreement with Lilly

ARC enters research agreement with McGill University for antisense oligonucleotide therapeutics

ProdiGene and NIAID to begin phase I trial of oral traveler's diarrhea vaccine

Phase I solid tumor trial initiated for KSP inhibitor

Salicylate protects against the ototoxic and nephrotoxic side effects of cisplatin in rats

Iressa NSCLC trial results show no improvement in combined treatment with standard chemotherapy

Potent, selective and orally bioavailable FTase inhibitor presented by Abbott

Ras-MAPK signaling cascade inhibitors prepared and tested at Wyeth

Abbott reports novel HDAC inhibitors at the ACS meeting

Merck & Co. discloses novel HIV protease inhibitors

Nocathiacin I derivatives with in vivo antibacterial activity presented at ACS

New PPARalpha/delta receptor agonists covered by GSK patent

Merck claims alphavbeta3 and/or alphavbeta6 antagonists for cardiovascular and other disorders

Novel prostaglandin EP4 antagonists and their use in neuropathic pain

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...